News & Analysis as of

Private Equity Non-Compete Agreements Corporate Practice of Medicine

King & Spalding

Oregon Enacts Further Restrictions Against Private Equity Investment in Medical Practices

King & Spalding on

Last week, Oregon enacted into law SB951, which strengthens Oregon’s corporate practice of medicine doctrine by implementing greater restrictions on arrangements between medical practices and management services organizations...more

Mintz - Health Care Viewpoints

Oregon Law Restricts Common Management Service Organization – Professional Entity Structure

On June 9, 2025, Oregon Governor Tina Kotek signed into law Oregon Senate Bill 951 (Oregon CPOM Law), further expanding Oregon’s prohibition on the corporate practice of medicine (CPOM) doctrine. The stated purpose of the...more

Arnall Golden Gregory LLP

New Oregon Law Strengthens Prohibition on the Corporate Practice of Medicine

On June 9, 2025, Oregon Governor Tina Kotek signed Senate Bill 951 (SB 951) into law. According to sponsors of SB 951, this new legislation is designed to curb the influence of private equity and third-party management...more

Sheppard Mullin Richter & Hampton LLP

Oregon Targets Corporate Practice of Medicine with Enacted Bill: What SB 951 Means for MSOs, PE-Backed Physician Groups, and...

Overview of SB 951 - Oregon Governor Tina Kotek on Monday, June 9, 2025, signed a first-of-its-kind law that significantly reshapes the state’s regulatory landscape for non-physician investment in medical practices. Senate...more

Proskauer - Health Care Law Brief

Oregon Governor Signs S.B. 951, Representing the Nation’s Most Onerous Restriction on the Friendly PC Model

Over the past 3 years, as chronicled in several Proskauer alerts, an increasing number of states have sought to regulate physician practice management (“PPM”) and private equity transactions in the health care sector,...more

McGuireWoods LLP

Oregon Enhances Restrictions on Corporate Practice of Medicine

McGuireWoods LLP on

On June 9, 2025, Oregon Senate Bill 951 (SB 951) was officially signed into law, significantly strengthening the state’s prohibition on the corporate practice of medicine. SB 951 restricts how professional medical practices...more

Benesch

Healthcare Private Equity Investment: As Federal Headwinds Subside, a Gale Warning Goes Up in Many States

Benesch on

Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns...more

Venable LLP

Event in Review: Antitrust in Healthcare: The Good, the Bad, and the Ugly

Venable LLP on

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely...more

Benesch

Valuation Trends in Private Equity, Nephrology, Dialysis, Value-Based Care and Outpatient Labs

Benesch on

Valuations, and how a business reacts to them, directly impact a business’s ability to complete successful transactions. In the healthcare sector, compliance with federal and state laws against self-referral and kickbacks and...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide